-
Cultivate "good" mosquitoes to fight dengue fever
Time of Update: 2021-11-11
According to the test results published in the New England Journal of Medicine in June this year, during the 27-month study period, the release of Wolbachia mosquitoes reduced the number of dengue fever cases in the test area by as much as 77%.
-
[Heavyweight] Yuandong’s first oral hypoglycemic drug will be approved, targeting Hausen’s star products
Time of Update: 2021-11-11
Figure 1: Yuandong's registration progress of repaglinide and metformin tablets Source: NMPA official website Repaglinide Metformin Tablets is a compound hypoglycemic drug that combines two different mechanisms of action to improve the blood sugar control of patients with type 2 diabetes.
-
Pfizer's new crown oral drug was clinically successful, Merck’s stock price fell nearly 10%, and neutralizing antibody and vaccine stocks fell again across the board
Time of Update: 2021-11-11
From: Pfizer official website Vaccine stocks and neutralizing antibody concept stocks once again fell across the board following the positive development of oral drugs .
The next day, following the announcement of Pfizer's new crown oral drug data, it fell by nearly 20%.
-
Lasker Prize winner Alberts talks about translational medicine
Time of Update: 2021-11-11
0 and Interdisciplinary Research Forum held on October 31, the 83-year-old former dean of the National Academy of Sciences in 2016 Professor Bruce Michael Alberts, the winner of the Special Achievement Award in Medicine, said with emotion .
-
Health Commission: 92 newly diagnosed cases on the 31st, 59 of which are in the local area
Time of Update: 2021-11-11
As of 24:00 on October 31, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 869 confirmed cases (including 33 severe cases), a total of 91,738 cured and discharged cases, and a total of 4,636 deaths.
-
Health Commission: 64 newly diagnosed cases on the 28th, including 48 local
Time of Update: 2021-11-11
As of 24:00 on October 28, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 701 confirmed cases (including 38 severe cases), a total of 91665 cured and discharged cases, and a total of 4636 deaths.
-
Health Commission: 109 newly diagnosed cases and 93 local cases on the 2nd
Time of Update: 2021-11-11
As of 24:00 on November 2, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 1,000 confirmed cases (including 37 severe cases), a total of 91,787 cured and discharged cases, and a total of 4,636 deaths.
-
Zhong Nanshan's team won the 2020 Science and Technology Progress Award Innovation Team Award
Time of Update: 2021-11-11
This is also a result of Zhong Nanshan's respiratory disease prevention and control innovation team promoting health science popularization and improving the national health level .
-
Pfizer announces voluntary recall of all batches of smoking cessation drug varenicline in the U.S.
Time of Update: 2021-11-05
He also stated that the health benefits of quitting smoking outweigh the theoretical potential carcinogenic risk of nitrosamine impurities in varenicline .
In 2020, Chantix generated sales of US$919 million for Pfizer, a year-on-year decrease of approximately 17.
-
Hisun Pharmaceutical's Valsartan Tablets Passed the Consistency Evaluation of Generic Drugs
Time of Update: 2021-11-05
On August 23, Hisun Pharmaceutical issued an announcement stating that the company had recently received the "Drug Registration Certificate" for valsartan tablets approved and issued by the State Drug Administration .
-
Eisai/Bojian AD antibody therapy lecanemab begins to submit rolling marketing application to FDA
Time of Update: 2021-11-05
On September 27, Eisai announced that it has begun rolling submissions to the US FDA through the accelerated approval channel for its research Alzheimer's disease (AD) antibody therapy lecanemab biological product license application (BLA) for early treatment AD .
-
Fuhong Henlius successfully concluded the 2021 Service and Trade Fair
Time of Update: 2021-11-05
Among Chinese pharmaceutical companies, as a representative of a number of innovations that have been harvested after only 11 years of establishment, Henlius is considered young; and the innate intern
-
What are the trends in Qilu and other detonating innovative drugs with 14 transaction amounts that exploded in license in?
Time of Update: 2021-11-05
From 2021 to the present, the transaction amount exceeds 100 million US dollars in license inBiotech companies with capital market intervention, Biopharma with commercialized products, and Big Pharma with good financial status are the mainstream importers .
-
A total of 789 people in Taiwan died after receiving the new crown vaccine, mostly related to AstraZeneca vaccine
Time of Update: 2021-11-05
The Taichung City Health Bureau confirmed on the 22nd that a 92-year-old man received the second dose of AstraZeneca vaccine on September 16 .
-
Hengrui Medicine's ioverol injection passed the consistency evaluation of generic drugs
Time of Update: 2021-11-05
Ioverol injection is suitable for: 1.
Head and Enhanced CT scan of the body and excretory urography; 3.
Cardiovascular angiography, enhanced CT scan of the head and body, and excretory urography in children one year old or older .
-
This biosimilar approval document is worth 175 million yuan
Time of Update: 2021-11-05
Article source: Medical Rubik's Cube InfoAuthor: Shi BeiOn September 28, the official website of the State Food and Drug Administration showed that the marketing application of Hisun Pharmaceutical's infliximab biosimilar was officially approved by the NMPA .
-
Huibaoyuan Bio's new anti-cancer drug xylazine obtained clinical trial approval from the U.S. FDA
Time of Update: 2021-11-05
This study aims to evaluate the overall survival benefit and safety of JP001 combined with standard radiotherapy and chemotherapy for newly diagnosed GBM patients .
Combined with surgical resection and radiotherapy, the median survival can be extended to 12.
-
Sanofi's new-generation Pompe disease treatment is clinically approved in China
Time of Update: 2021-11-05
Text|Pharmaceutical Mission HillsAccording to the latest announcement on the official website of the Center for Drug Evaluation (CDE) of the State Food and Drug Administration, Sanofi (Sanofi) declared a new class 1 drug avalglucosidase alfa, which has obtained the implied license for clinical trials, and plans to develop an enzyme replacement for patients with early-onset Pompe disease Treatment .
-
The sixth batch of countries organize centralized drug procurement (insulin special) into the reporting stage
Time of Update: 2021-11-05
On September 13, the National Organization for Drug Joint Procurement Office issued a notice on reporting the sixth batch of nationally organized drug centralized procurement (insulin specific) medical institutions' demand .
Data reporting is done online, and the medical institution reports the historical purchase volume and purchase demand volume based on the company’s products .
-
The first domestic product! First in class small molecule MIF inhibitor application for clinical application
Time of Update: 2021-11-05
Article source: Medical Rubik's Cube InfoOn September 26, the official website of the Center for Drug Evaluation (CDE) of the State Food and Drug Administration showed that the clinical application of Amifi Bio-targeted MIF small molecule inhibitor IPG1094 tablets was accepted by the State Food and Drug Administration .
